Hanoi (VNA) - Deputy Prime Minister Vu Duc Dam has asked for completionof the dossier of the homegrown Nano Covax vaccine to submit for urgent licencing, and assistance for relevant firms in testing the anti-virus drug Molnupiravir in a notice released by the Government Office.
In Notice No. 248/TB-VPCP, which sums up the conclusion of the Deputy PM at a meetingon research, technology transfer, clinical trial and production of drugs, vaccines, and biological products, the Ministry of Health is required to give more support to COVID-19 vaccine researchunits in completing and supplementing dossiers of vaccines, first of all the Nano Covax, to submit to the National Committee for Ethics in Biomedical Research, and the Advisory Council for theRegistration of Circulation of Drugs and Medicinal Ingredients forconsideration and emergency approval .
Deputy PM Dam also asks the MOH to collect recommendations of the two councils’members on the use of COVID-19 vaccines for children, the combination of vaccines, and plans for vaccine use in 2020.
The MoH is also asked to guide and help related firms in the trialof the anti-viral drug Molnupiravir, and design plans to ensure the availabilityof treatment drugs to meet the demand in the situation of rapid increases in COVID-19 patients, while speeding up the clinical trial and evaluation ofthe efficacy of the Vipdevir drug for COVID-19 treatment researchedand produced by the Vietnam Academy of Science and Technology.
Theministry will also direct domestic units to continue researching medicine forCOVID-19 treatment, coordinate will the Ministry of Science and Technology andrelevant agencies in helping enterprises to soon produce rapidantigen testing kits which can be effectiveon many strains of SARS-CoV-2 virus./.
Deputy PM Dam also asks the MOH to collect recommendations of the two councils’members on the use of COVID-19 vaccines for children, the combination of vaccines, and plans for vaccine use in 2020.
The MoH is also asked to guide and help related firms in the trialof the anti-viral drug Molnupiravir, and design plans to ensure the availabilityof treatment drugs to meet the demand in the situation of rapid increases in COVID-19 patients, while speeding up the clinical trial and evaluation ofthe efficacy of the Vipdevir drug for COVID-19 treatment researchedand produced by the Vietnam Academy of Science and Technology.
Theministry will also direct domestic units to continue researching medicine forCOVID-19 treatment, coordinate will the Ministry of Science and Technology andrelevant agencies in helping enterprises to soon produce rapidantigen testing kits which can be effectiveon many strains of SARS-CoV-2 virus./.
VNA